跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PROHANCE gadoteridol 2793mg/10mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
PROHANCE gadoteridol 2793mg/10mL injection vial
Approved
STANDARD
PROHANCE gadoteridol 2793mg/10mL injection vial
Bracco Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
9bdab39ece0338fd
Company
Bracco Pty Ltd
Type
Standard
Approval Details
Approval Id
9bdab39ece0338fd
Product Name
PROHANCE gadoteridol 2793mg/10mL injection vial
Artg Id
263733
Artg Name
PROHANCE gadoteridol 2793mg/10mL injection vial
Sponsor
Bracco Pty Ltd
Company Detail Path
/organization/c-and-r-bracco-pty-ltd
Artg Date
2016-04-26
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/f542224ee3a9d06701a231068b326358.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3803ab43fdcea007b8636c4a55ffed9f.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
9bdab39ece0338fd
Type
Standard
Back to TGA Approvals